论文部分内容阅读
我们观察了82例Graves病患者在治疗前后血浆β内啡吠(β-EP)水平的变化.现报道如下.对象与方法对象:随机选择Graves病患者82例,男性13例,女性69例.平均年龄38.6±11岁.病程1个月至6年.入选条件:(1)临床有典型甲亢症状;(2)T_3、T_4、rT_3、TSH检测符合甲亢诊断标准;(3)排除糖尿病、心、肝、肺、脑血管意外等其它疾患.将82例分为三组:(1)A组30例,女性26例,男性4例,平均年龄39.03±9.6岁,比较抗甲状腺药物ATD治疗前后血浆β-EP的变化;(2)B组26例,男性5例,女性21例,平均年龄38.3±13岁,处于甲
We observed 82 patients with Graves disease before and after treatment of plasma beta endorphin (β-EP) level changes are reported as follows.Material and Methods Subjects: 82 patients were randomly selected Graves disease, 13 males and 69 females. The average age was 38.6 ± 11 years and the course of disease ranged from 1 month to 6 years.Collecting conditions: (1) The clinical symptoms of typical hyperthyroidism; (2) T_3, T_4, rT_3 and TSH were in accordance with the diagnostic criteria of hyperthyroidism; (3) , Liver, lung and cerebrovascular accident, etc. 82 cases were divided into three groups: (1) 30 cases in group A, 26 cases in female and 4 cases in males, with an average age of 39.03 ± 9.6 years. Before and after anti-thyroid drug treatment, Plasma β-EP changes; (2) B group of 26 patients, 5 males and 21 females, mean age 38.3 ± 13 years, in a